{"id":206927,"date":"2025-02-21T07:33:13","date_gmt":"2025-02-21T13:33:13","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/02\/car-t-cells-enable-record-breaking-18-year-nerve-cancer-remission"},"modified":"2025-02-21T07:33:13","modified_gmt":"2025-02-21T13:33:13","slug":"car-t-cells-enable-record-breaking-18-year-nerve-cancer-remission","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/02\/car-t-cells-enable-record-breaking-18-year-nerve-cancer-remission","title":{"rendered":"CAR T-cells enable record-breaking 18-year nerve cancer remission"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/car-t-cells-enable-record-breaking-18-year-nerve-cancer-remission.jpg\"><\/a><\/p>\n<p>A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years.\u2060 \u2060 \u201cThis is, to my knowledge, the longest-lasting complete remission in a patient who received CAR T-cell therapy,\u201d says Karin Straathof at University College London, who wasn\u2019t involved in the treatment. \u201cThis patient is cured,\u201d she says.\u2060 \u2060 Doctors use CAR T-cell therapy to treat some kinds of blood cancer, like leukaemia. To do this, they collect a sample of T-cells, which form part of the immune system, from a patient\u2019s blood and genetically engineer them to target and kill cancer cells. They then infuse the modified cells back into the body. In 2022, a follow-up study found that this approach had put two people with leukaemia into remission for around 11 years, a record at the time.\u2060 \u2060<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years.\u2060 \u2060 \u201cThis is, to my knowledge, the longest-lasting complete remission in a patient who received CAR T-cell therapy,\u201d says Karin Straathof at University College London, who wasn\u2019t [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-206927","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/206927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=206927"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/206927\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=206927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=206927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=206927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}